Key points from article :
Pandorum Technologies, an Indian biotechnology company, is developing a regenerative treatment for corneal blindness, a condition affecting millions worldwide.
Their "liquid cornea" technology uses regenerative exosomes to promote scarless healing of damaged corneal tissue, potentially restoring vision.
Researchers at Pandorum Technologies, with labs in India and the United States, are conducting the research.
Pre-clinical studies show promising results in regenerating corneal tissue and restoring vision.
Pandorum secured $11 million in funding to advance the therapy to human trials, beginning the process of clinical testing with the aim of starting patient treatments in 2025.
The company's technology also shows potential for regenerative treatments for liver, lung, and neuronal (nerve-related) tissues.
